Early inflammation and the development of pulmonary disease in cystic fibrosis

Pediatric Pulmonology

Volumn 24, Issue SUPPL. 16, 1997, Pages 267-268

  Wagener, J S ^a   Kahn, T Z ^a   Copenhaver, S C ^a   Accurso, F J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; CONFERENCE PAPER; CYSTIC FIBROSIS; HUMAN; INFECTION RISK; LUNG DISEASE; LUNG LAVAGE; PRIORITY JOURNAL; CHILD; CLINICAL TRIAL; CYTOLOGY; DOWN REGULATION; FOLLOW UP; INFANT; INFLAMMATION; METABOLISM; MICROBIOLOGY; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; REVIEW;

CFTR PROTEIN, HUMAN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DOWN-REGULATION; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; RESPIRATORY TRACT INFECTIONS;

EID: 0031304729     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.19502308138     Document Type: Conference Paper

References (12)

1. Konstan MW, Milliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994; 150:448-454.
2. Kahn TZ, Wagener .IS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995; 151;1075-1082.
3. Armstrong DS, Grimwood K, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br Med J. 1995; 310:1571-1573.
4. Wilmott RW, Kassab .IT, Killian PL, Benjamin WR, Douglas SD, Wood RE. Increased levels of interleukin-1 in bronchoalveolar lavage washings from children with bacterial pulmonary infections. Am Rev Respir Dis. 1990; 142:365-368.
5. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, LiechteGallati S, Kraemer R, Hubbard R, Crystal RG. Proteaseantiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med. 1994; 150:207-213.
6. Balough K, McCubbin M, Pick R. The relationship between infection and inflanunation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol. 1995; 20:63-70.
7. Ramsey BW, Wentz WR, Smith AL, Richardson M, WilliamsWarren J, Dedges Dl, Gibson R, Redding GJ, Lent K, Harris K. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis. 1991; 144:331-333.
8. Bonfield Tl, Konstan MW, Burfeind P, Panuska JR, Milliard JB, Berger M Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol. 1995; 13:257-261.
9. Meyer KC, Lewandoski JR, Zimmerman JJ, Nunley D, Calhoun WJ, Dopico GA. Human neutrophil elastase and elastase/alpha-1-antiprotease complex in cystic fibrosis: Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am Rev Respir Dis. 1991;l44:580-585.
10. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of highdose ibuprofen in patients with cystic fibrosis. New Engl J Med. 1995; 332:848-854.
11. Eigen H, Rosenstein BJ, Fitzsimmons S, Shidlow DV. A multi-center sttidy of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr. 1995; 126:515-523.
12. van Hären EH.I, Lammers J-WJ, Festen J, Heijerman HGM, Groot Car, van Herwaarden CLA. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med. 1995; 89:209-214.